NICORETTE® - For every cigarette there's a NICORETTE® - Print Logo

Reference

(1) US Department of Health and Human services. A report of the Surgeon General. The health benefits of smoking cessation. Washington DC, 1990

(2) Gourly Sg, Bonowitz NL. The benefits of stopping smoking and the role of nicotine replacement therapy in older patients. Drugs & Aging 1996; 9: 8-23

(3) Batra A, Klingler K, Landfeldt B, et al. Smoking reduction treatment with 4-mg nicotine gum: A doubleblind, randomized, placebo-con¬trolled study. Clin Pharmacol Ther 2005;78:689-96.

(4) Sachs DPL, Sawe U, Scott J, et al. Effectiveness of a 16-Hour Transdermal Nicotine Patch in a Medical Practice Setting, Without Intensive Group Counseling. Arch Intern Med 1993; 153: 1881-90.

(5) Shiffman S, Dresler CM, Hajek P, et al. Efficacy of a Nicotine Lozenge for Smoking Cessation. Arch Intern Med 2002; 162: 1267-76.

(6) Hughes JR. Risk – benefit assessment of nicotine preparations in smoking cessation. Drug Saf 1993; 8: 49-56

(7) Smith CJ, Livingston SD, Doolittle DJ. An international literature survey of ‘IARC group I carcinogens’ reported in mainstream cigarette smoke. Food Chem Toxicol 1997; 35: 1107-1130

(8) Benowitz NL. Nicotine addiction. Prim Care 1999; 26: 611-631

(9) De Witt D, Zacny J. Abuse potential of nicotine replacement therapies. CNS Drugs 1995; 4: 456-468

(10) Wennike P, Danielsson T, Landfeldt B, et al. Smoking reduction promotes cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow up. Addiction 2003; 98: 1395-1402.

(11) Bolliger CT, Zellweger J-P, Danielsson T, et al. Smoking reduction with oral nicotine inhalers: double blind, randomized clinical trial of effi cacy and safety. BMJ 2000;321:329-33.

(12) Nicotine Assisted Reduction to Stop (NARS) – Guidance for Health Professionals on this New Indication for Nicotine Replacement Therapy ASH; 2005 Oct; London, Great Britain